143 related articles for article (PubMed ID: 36781089)
1. PD-1: A New Candidate Target for Analgesic Peptide Design.
Zhao L; Ma Y; Song X; Wu Y; Jin P; Chen G
J Pain; 2023 Jul; 24(7):1142-1150. PubMed ID: 36781089
[TBL] [Abstract][Full Text] [Related]
2. An analgesic peptide H-20 attenuates chronic pain via the PD-1 pathway with few adverse effects.
Zhao L; Luo H; Ma Y; Zhu S; Wu Y; Lu M; Yao X; Liu X; Chen G
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2204114119. PubMed ID: 35878019
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1.
Chen G; Kim YH; Li H; Luo H; Liu DL; Zhang ZJ; Lay M; Chang W; Zhang YQ; Ji RR
Nat Neurosci; 2017 Jul; 20(7):917-926. PubMed ID: 28530662
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TRPV1 by SHP-1 in nociceptive primary sensory neurons is critical in PD-L1 analgesia.
Liu BL; Cao QL; Zhao X; Liu HZ; Zhang YQ
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32960817
[TBL] [Abstract][Full Text] [Related]
5. Electroacupuncture Alleviates CFA-Induced Inflammatory Pain via PD-L1/PD-1-SHP-1 Pathway.
Deng D; Xu F; Ma L; Zhang T; Wang Y; Huang S; Zhao W; Chen X
Mol Neurobiol; 2023 May; 60(5):2922-2936. PubMed ID: 36753045
[TBL] [Abstract][Full Text] [Related]
6. G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides.
Daniel JT; Clark RJ
Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29144441
[TBL] [Abstract][Full Text] [Related]
7. A novel α-conopeptide Eu1.6 inhibits N-type (Ca
Liu Z; Bartels P; Sadeghi M; Du T; Dai Q; Zhu C; Yu S; Wang S; Dong M; Sun T; Guo J; Peng S; Jiang L; Adams DJ; Dai Q
Sci Rep; 2018 Jan; 8(1):1004. PubMed ID: 29343689
[TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide disturbing GluN2A/SHP1 interaction in dorsal root ganglion attenuated pathological pain.
He YT; Duan XL; Guo Z; Li HL; Suo ZW; Yang X; Zhang MY; Hu XD
Eur J Pharmacol; 2019 Jul; 854():62-69. PubMed ID: 30951721
[TBL] [Abstract][Full Text] [Related]
9. The Programmed Cell Death Ligand-1/Programmed Cell Death-1 Pathway Mediates Pregnancy-Induced Analgesia via Regulating Spinal Inflammatory Cytokines.
Tan H; Ding Z; Zhang C; Yan J; Yang Y; Li P
Anesth Analg; 2021 Nov; 133(5):1321-1330. PubMed ID: 34524124
[TBL] [Abstract][Full Text] [Related]
10. Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms.
Peng X; Studholme K; Kanjiya MP; Luk J; Bogdan D; Elmes MW; Carbonetti G; Tong S; Gary Teng YH; Rizzo RC; Li H; Deutsch DG; Ojima I; Rebecchi MJ; Puopolo M; Kaczocha M
Mol Pain; 2017 Jan; 13():1744806917697007. PubMed ID: 28326944
[TBL] [Abstract][Full Text] [Related]
11. Two-pore domain potassium channels: emerging targets for novel analgesic drugs: IUPHAR Review 26.
Gada K; Plant LD
Br J Pharmacol; 2019 Jan; 176(2):256-266. PubMed ID: 30325008
[TBL] [Abstract][Full Text] [Related]
12. Interaction and regulatory functions of μ- and δ-opioid receptors in nociceptive afferent neurons.
Zhang X; Bao L
Neurosci Bull; 2012 Apr; 28(2):121-30. PubMed ID: 22466123
[TBL] [Abstract][Full Text] [Related]
13. Effect of the hairpin structure of peptide inhibitors on the blockade of PD-1/PD-L1 axis.
Wang K; Song Y; Su Y; Liang Y; Wang L
Biochem Biophys Res Commun; 2020 Jun; 527(2):453-457. PubMed ID: 32336542
[TBL] [Abstract][Full Text] [Related]
14. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
Sun J; Chen SR; Chen H; Pan HL
J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
[TBL] [Abstract][Full Text] [Related]
15. A novel isoquinoline alkaloid HJ-69 isolated from Zanthoxylum bungeanum attenuates inflammatory pain by inhibiting voltage-gated sodium and potassium channels.
Wang L; Hao H; Meng X; Zhang W; Zhang Y; Chai T; Wang X; Gao Z; Zheng Y; Yang J
J Ethnopharmacol; 2024 Aug; 330():118218. PubMed ID: 38677570
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 and PD-1 expressed in trigeminal ganglia may inhibit pain in an acute migraine model.
Shi S; Han Y; Wang D; Guo P; Wang J; Ren T; Wang W
Cephalalgia; 2020 Mar; 40(3):288-298. PubMed ID: 31640402
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in non-opioid analgesic peptides.
Pérez de Vega MJ; Ferrer-Montiel A; González-Muñiz R
Arch Biochem Biophys; 2018 Dec; 660():36-52. PubMed ID: 30342013
[TBL] [Abstract][Full Text] [Related]
18. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.
Yokosuka T; Takamatsu M; Kobayashi-Imanishi W; Hashimoto-Tane A; Azuma M; Saito T
J Exp Med; 2012 Jun; 209(6):1201-17. PubMed ID: 22641383
[TBL] [Abstract][Full Text] [Related]
19. The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ- and κ-opioid receptors.
Xu B; Zhang M; Shi X; Zhang R; Chen D; Chen Y; Wang Z; Qiu Y; Zhang T; Xu K; Zhang X; Liedtke W; Wang R; Fang Q
Br J Pharmacol; 2020 Jan; 177(1):93-109. PubMed ID: 31444977
[TBL] [Abstract][Full Text] [Related]
20. Development of the Inhibitors that Target the PD-1/PD-L1 Interaction-A Brief Look at Progress on Small Molecules, Peptides and Macrocycles.
Guzik K; Tomala M; Muszak D; Konieczny M; Hec A; Błaszkiewicz U; Pustuła M; Butera R; Dömling A; Holak TA
Molecules; 2019 May; 24(11):. PubMed ID: 31151293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]